希斯甲基转移酶作为沃里诺斯塔特表观遗传作用的新点
Varvara Maksimova1, Julia Makus1,2, Valeriia Popova1,3
1Blokhin National Medical Research Center of Oncology, Moscow, 115478, Russia.
Biochemistry. Biokhimiia
|September 26, 2023
概括
沃里诺斯塔特 (SAHA) 影响了超越基因组脱乙酶的表观遗传调节. 这项研究表明,伏利诺斯塔特还抑制了关键的组分素甲基化酶,这表明在癌症治疗中具有更广泛的治疗潜力.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症研究 癌症研究
背景情况:
- 恶性细胞的转化涉及异常的基因素甲基化和乙化.
- 沃里诺斯塔特 (SAHA) 是一种在瘤学中使用的表观遗传药物,主要以抑制基因组脱乙酶 (HDACs) 而闻名.
- 伏利诺斯塔特对基因素甲基化酶的影响在很大程度上尚未研究.
研究的目的:
- 为了研究伏利诺斯塔特对基因素甲基化酶的影响.
- 扩大对沃里诺斯塔特的表观遗传作用机制的理解.
主要方法:
- 使用HeLa TI细胞进行化合物评估.
- 通过GFP记者基因表达和小干扰RNA (siRNA) 基因敲除来评估效应.
- 使用西式涂抹证实了酶表达的变化.
主要成果:
- 伏利诺斯塔特抑制了HDAC1的活动.
- 沃里诺斯塔特降低了EZH2,SUV39H1,SUV39H2和SUV420H1.1的活性和表达.
- 沃里诺斯塔特还降低了SUV420H2和DOT1L酶的表达.
结论:
- 沃里诺斯塔特的表观遗传效应延伸到质子甲基化抑制.
- 这些发现需要进一步大规模分析vorinostat对各种表观遗传酶的活性.
- 了解vorinostat的全部表观遗传机制可以优化其用于治疗异常表观遗传特征的癌症.
相关概念视频
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Histone Modification
3.5K
3.5K
Eukaryotic Transcription Inhibitors
9.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
Phase II Reactions: Methylation Reactions
220
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
220
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K


